Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review

Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review

BackgroundCOVID-19 may present different degrees of severity. Viral infections in patients with rheumatic inflammatory diseases (R-IMID) trend to present more severe disease. However, data comparing the severity of the disease between R-IMID and the general population are scarce.ObjectivesTo compare...

Full description

Bibliographic Details
Main Authors: David Martínez-López, Ivan Ferraz-Amaro, Diana Prieto-Peña, Lara Sánchez-Bilbao, Alba Herrero-Morant, Carmen Álvarez-Reguera, Fabricio Benavides-Villanueva, Cristina Corrales-Selaya, Martín Trigueros-Vázquez, Miguel Ángel González-Gay, Ricardo Blanco
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Medicine
Subjects:
COVID-19
autoimmune diseases
antirheumatic agents
rituximab
biologic agents
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1056374/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1056374/full

Similar Items